Prediction of Sarcopenia Onset in Type 2 Diabetes Using Urinary Titin Levels: A Japanese Prospective Cohort Study
Diabetes Care · 01.10.2025 · 48 (10) · 1844-1849
DOI: 10.2337/dc25-1067 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Diabetes Care, online erschienen am 25.08.2025. Verfasst von Hayato Tanabe und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes, Endocrinology, and Metabolism, Fukushima Medical University School of Medicine, Fukushima, Japan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Connectin, Sarcopenia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science (JSPS), AMED, Japan Agency for Medical Research and Development.
Themen: Diabetes mellitus
Abstract (Originalsprache)
OBJECTIVE The predictive power of urinary titin for incident sarcopenia was studied in Japanese individuals with type 2 diabetes. RESEARCH DESIGN AND METHODS Baseline urinary titin levels were measured, and sarcopenia was evaluated annually using the Asian Working Group for Sarcopenia (AWGS) 2019 criteria. Kaplan-Meier curves, Cox models, and time-dependent receiver operating characteristic analyses were used to assess incident sarcopenia. RESULTS Among 444 participants (median follow-up, 1,078 days), 41 developed sarcopenia. The high titin tertile was associated with an elevated sarcopenia risk (log-rank P = 0.04). Cox models associated titin with sarcopenia (adjusted hazard ratio per SD 1.37, 95% CI 1.05–1.77, P = 0.019) and low muscle strength. Risk estimates were consistent across subgroups, including those aged ≥70 years, men, individuals with BMI <25 kg/m2, HbA1c ≥7%, and estimated glomerular filtration rate ≥60 mL/min/1.73 m2 (P for interaction > 0.05). CONCLUSIONS Elevated urinary titin levels predict sarcopenia and low muscle strength in individuals with type 2 diabetes, supporting its use as a noninvasive biomarker.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Diabetes, Endocrinology, and Metabolism, Fukushima Medical University School of Medicine, Fukushima, Japan.
- Department of Diabetes, Endocrinology, and Metabolism, and General Internal Medicine, Fukushima Medical University School of Medicine, Fukushima, Japan.
- Department of Nutrition and Metabolism, Institute of Biomedical Sciences, Tokushima University, Tokushima, Japan.
- Graduate School of Science, Technology, and Innovation, Kobe University, Kobe, Japan.
ORCID-Profile: Michio Shimabukuro
Förderung
- Japan Society for the Promotion of Science (JSPS)
- AMED
- Japan Agency for Medical Research and Development
Zitieren
APA
Tanabe, H., Takiguchi, Y., Tsutsumi, R., Shiroma, K., Hyodo, M., Izumi-Mishima, Y., Nomura, K., Matsuo, M., Sakaue, H., & Shimabukuro, M. (2025). Prediction of Sarcopenia Onset in Type 2 Diabetes Using Urinary Titin Levels: A Japanese Prospective Cohort Study. Diabetes Care, 48(10), 1844-1849. https://doi.org/10.2337/dc25-1067
Vancouver
Tanabe H, Takiguchi Y, Tsutsumi R, Shiroma K, Hyodo M, Izumi-Mishima Y, et al. Prediction of Sarcopenia Onset in Type 2 Diabetes Using Urinary Titin Levels: A Japanese Prospective Cohort Study. Diabetes Care. 2025;48(10):1844-1849. doi:10.2337/dc25-1067
BibTeX
@article{Tanabe2025,
author = {Tanabe, Hayato and Takiguchi, Yoshinori and Tsutsumi, Rie and Shiroma, Kaori and Hyodo, Mizusa and Izumi-Mishima, Yuna and Nomura, Kazuhiro and Matsuo, Masafumi and Sakaue, Hiroshi and Shimabukuro, Michio},
title = {Prediction of Sarcopenia Onset in Type 2 Diabetes Using Urinary Titin Levels: A Japanese Prospective Cohort Study},
journal = {Diabetes Care},
year = {2025},
volume = {48},
number = {10},
pages = {1844--1849},
doi = {10.2337/dc25-1067}
}
EUVIMED